心脏瓣膜外科术后口服华法林抗凝治疗监测策略探讨(4)
[1] Xu JP，Shi YK，Dong L，et al. Low intensity anticoagulation therapy for chinese population with heart valve replacement—3000 cases follow-up [J]. Sichuan Da Xue Xue Bao Yi Xue Ban，2016，47(1)：90-92.[2] 张瑜，游鹏程，郑秋山.115例华法林临床应用调查分析[J].中国药物警戒，2011，8(9)：524-527.
[3] Wypasek E，Ciesla M，Suder B，et al. CYP2C9 polymorphism and unstable anticoagulation with warfarin in patients within the first 3 months following heart valve replacement [J]. Adv Clin Exp Med ......
您现在查看是摘要页，全文长 2782 字符。